Genprex Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$2.20

+0.24 (+12.24%)

As of Feb 8, 2:32 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Moderate

Coverage

Buy 6 86%

Hold 1 14%

Sell 0 0%

Price Target

Analyst Price Target +1,157.3% upside

Low Target $20.34

Average Target $27.66

High Target $35.38

Current Price $2.20

Current
$2.20

Target
$27.66

$20.34 $27.66 avg $35.38

Scenario Analysis

Bear Case

$20.34

824.5%

Low target

Base Case

$27.66

+1,157.3%

Avg target

Bull Case

$35.38

+1,508.2%

High target

Risk/Reward

1.8x

Balanced

Price in Context

52-Week High

$29.32

-92.5% from high

52-Week Low

$16.08

+-86.3% from low

Target vs 52W High

$27.66

-5.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Buy	37	68%	$257.58	+15.3%
AMGN Amgen Inc	Hold	41	54%	$190.87	-50.3%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.8%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	39	77%	$438.34	-8.3%
REGN Regeneron Pharmaceuticals	Strong Buy	36	75%	$76.80	-90.2%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	36	75%	$102.31	-68.8%
INSM Insmed Inc	Strong Buy	27	93%	$143.40	-4.3%
BIIB Biogen Inc	Hold	42	48%	$91.45	-54.5%